Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Talk to your pharmacist for more details
Mounjaro was approved in the US for treating Type 2 diabetes in 2022, and in 2023, the same active ingredient, tirzepatide, was approved in the US for treating chronic weight management under the brand name, Zepbound
Invalid results or an error can occur for many reasons
This stress is a major culprit behind aging, inflammation, and a host of chronic diseases
Service was great and the delivery right on time I was pleased with the delivery speedbut unhappy that the bottle and its contents were pretty warm upon arrival
US$ 24.09
US$ 22.40
US$ 25.60
US$ 28.01
:max_bytes(150000):strip_icc()/GettyImages-2126120280-779987b12a5146d5b07f4e3ee57b3c3b.jpg)
US$ 22.41
US$ 25.54
US$ 26.69
US$ 27.88
